KEITH C MEYER, MD
Osteopathic Medicine at Highland Ave, Madison, WI
License number
Wisconsin 24997
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
600 Highland Ave, Madison, WI 53792
Phone
(608) 263-7203
(608) 263-9103 (Fax)
(608) 263-9103 (Fax)
Professional information
Dr. Keith C Meyer, Madison WI - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
600 Highland Ave STE J5, Madison 53792
(608) 263-7203 (Phone), (608) 833-6932 (Fax)
University of Wisconsin Hospital and Clinics
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
UW Health Pulmonary Med Clin
600 Highland Ave STE B6242, Madison 53792
(608) 263-7203 (Phone)
(608) 263-7203 (Phone), (608) 833-6932 (Fax)
University of Wisconsin Hospital and Clinics
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
UW Health Pulmonary Med Clin
600 Highland Ave STE B6242, Madison 53792
(608) 263-7203 (Phone)
Certifications:
Critical Care Medicine, 1989, Internal Medicine, 1984, Pulmonary Disease, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
600 Highland Ave STE J5, Madison 53792
University of Wisconsin Hospital and Clinics
600 Highland Ave, Madison 53792
UW Health Pulmonary Med Clin
600 Highland Ave STE B6242, Madison 53792
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
University of Wisconsin Hospital and Clinics
600 Highland Ave, Madison 53792
UW Health Pulmonary Med Clin
600 Highland Ave STE B6242, Madison 53792
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
University Of Wisconsin Medical School
Graduated: 1981
University Of Wisconsin Madison
Graduated: 1982
Graduated: 1984
Graduated: 1988
University Of Wisconsin Medical School
Graduated: 1981
University Of Wisconsin Madison
Graduated: 1982
Graduated: 1984
Graduated: 1988
Keith C Meyer, Madison WI
Specialties:
Pulmonologist
Address:
600 Highland Ave, Madison, WI 53792
Education:
University of Wisconsin, School of Medicine and Public Health - Doctor of Medicine
University of Wisconsin Hospital & Clinics - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)
University of Wisconsin Hospital & Clinics - Residency - Internal Medicine
University of Wisconsin Hospital & Clinics - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)
University of Wisconsin Hospital & Clinics - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Professor At Uw
Position:
Professor at UW
Location:
Madison, Wisconsin Area
Industry:
Medical Practice
Work:
UW
-
Professor
Keith Carl Meyer, Middleton WI
Specialties:
Internal Medicine, Pulmonary Disease, Critical Care Medicine
Work:
UW Medical Foundation
7974 Uw Health Ct, Middleton, WI 53562
7974 Uw Health Ct, Middleton, WI 53562
Education:
University of Wisconsin at Madison (1981)
Method For Measuring Activity Of A Specific Fraction Of Albumin
US Patent:
7968306, Jun 28, 2011
Filed:
Dec 12, 2008
Appl. No.:
12/334084
Inventors:
Francis H. C. Tsao - Madison WI, US
Keith C. Meyer - Middleton WI, US
Keith C. Meyer - Middleton WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
G01N 1/00, G01N 33/53
US Classification:
435 721, 435 71, 436501, 436506, 436518, 424 111, 424 121
Abstract:
Methods of measuring the SFA and sPLAactivities in a mammalian subject are provided. The methods include: providing a substrate comprising a fluorescently labeled carboxylic acid and a negatively charged phospholipid in an organic solvent such as ethanol, mixing the substrate with phospholipase Aand a biological sample from the subject, and detecting the fluorescence intensity change to determine the SFA and sPLAactivity in the sample. A decrease in SFA activity in the test sample as compared to the SFA activity in the control sample indicates that the subject has developed or is about to develop inflammation. An increase in sPLAactivity in the test sample as compared to the sPLAactivity in the control sample indicates that the subject has developed or is about to develop inflammation. Further disclosed is a kit for practicing the above methods.
Method And Composition For Treating Sleep Apnea
US Patent:
2002009, Jul 25, 2002
Filed:
Dec 10, 2001
Appl. No.:
10/016474
Inventors:
Keith Meyer - Middleton WI, US
M. Badr - West Bloomfield MI, US
M. Badr - West Bloomfield MI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K031/685, A61L009/04
US Classification:
514/076000, 424/045000
Abstract:
Application of synthetic or naturally occurring lung surfactant to the posterior pharyngeal region prior to a period of sleep significantly reduces episodes of sleep disturbance resulting in apnea or hypopnea. The present invention provides lung surfactant in a convenient applicator container for easy use and storage. Incidents of oxygen desaturation are reduced, thereby lowering the risks of apnea-associated pathologies.
Fluorescent Phospholipase Assay, Phospholipase A2 Inhibitor And Stimulator, And The Use Thereof
US Patent:
7579156, Aug 25, 2009
Filed:
Feb 12, 2003
Appl. No.:
10/365738
Inventors:
Francis H. C. Tsao - Madison WI, US
Keith C. Meyer - Middleton WI, US
Keith C. Meyer - Middleton WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
G01N 33/53, G01N 33/543
US Classification:
435 71, 436501, 436506, 436518, 424 111, 424 121
Abstract:
A fluorescent phospholipase assay is disclosed. Further disclosed are the identification of alpha-1-antitrypsin as a phospholipase Astimulator and phospholipase C inhibitor and the identification of mercaptalbumin as a phospholipase Ainhibitor. Various applications involving the use of the phospholipase assay, alpha-1-antitrypsin and mercaptalbumin are also disclosed.
Method And Composition For Treating Sleep Apnea
US Patent:
5958902, Sep 28, 1999
Filed:
Apr 16, 1997
Appl. No.:
8/834369
Inventors:
Keith C. Meyer - Middleton WI
M. Safwan Badr - West Bloomfield MI
M. Safwan Badr - West Bloomfield MI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 31685
US Classification:
514 76
Abstract:
Application of synthetic or naturally occurring lung surfactant to the posterior pharyngeal region prior to a period of sleep significantly reduces episodes of sleep disturbance resulting in apnea or hypopnea. The present invention provides lung surfactant in a convenient applicator container for easy use and storage. Incidents of oxygen desaturation are reduced, thereby lowering the risks of apnea-associated pathologies.
Method And Composition For Treating Sleep Apnea
US Patent:
6329352, Dec 11, 2001
Filed:
May 17, 1999
Appl. No.:
9/313110
Inventors:
Keith C. Meyer - Middleton WI
M. Safwan Badr - West Bloomfield MI
M. Safwan Badr - West Bloomfield MI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 31685
US Classification:
514 76
Abstract:
Application of synthetic or naturally occurring lung surfactant to the posterior pharyngeal region prior to a period of sleep significantly reduces episodes of sleep disturbance resulting in apnea or hypopnea. The present invention provides lung surfactant in a convenient applicator container for easy use and storage. Incidents of oxygen desaturation are reduced, thereby lowering the risks of apnea-associated pathologies.